<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Parvovirus B19 Infection - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Parvovirus B19 Infection</span>
        </nav>

        <header class="page-header">
            <h1>Parvovirus B19 Infection</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Viral Disease</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0006544" target="_blank">
                        MONDO:0006544
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Infectious Disease</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Childhood Infection</span>
                
            </div>
            
            <p style="margin-top: 16px; font-size: 1rem; line-height: 1.6; opacity: 0.95; position: relative;">
                Parvovirus B19 is a single-stranded DNA virus that primarily infects erythroid progenitor cells, causing erythema infectiosum (fifth disease) in children and arthropathy in adults. It can cause severe complications including transient aplastic crisis in patients with hemolytic disorders and hydrops fetalis in pregnant women.
            </p>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">6</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Genes</div>
            </div>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Viral Replication</div>
                
                <div class="item-desc">The virus primarily targets erythroid progenitor cells in the bone marrow, leading to disrupted red blood cell production.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Erythroid Progenitor Cells
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000038" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        viral genome replication
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0019079" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        DNA replication
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006260" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (7 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9372060" target="_blank">PMID:9372060</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Human parvovirus B19 shows remarkable tropism for human erythroid progenitor cells."</div>
                
                
                <div class="evidence-explanation">The abstract clearly states that Parvovirus B19 has a strong preference for infecting human erythroid progenitor cells.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26845771" target="_blank">PMID:26845771</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The pathogenic Parvovirus B19 (B19V) is characterized by a strict adaptation to erythroid progenitor cells (EPCs)..."</div>
                
                
                <div class="evidence-explanation">The study describes the infection dynamics of Parvovirus B19 in erythroid progenitor cells, supporting the statement that the virus primarily targets these cells.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37175911" target="_blank">PMID:37175911</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Parvovirus B19V (B19V) is a common human pathogen that infects bone marrow erythroid progenitor cells, leading to transient or persistent anemia."</div>
                
                
                <div class="evidence-explanation">The abstract mentions that Parvovirus B19 infects erythroid progenitor cells in the bone marrow, aligning with the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 4 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Immune Response</div>
                
                <div class="item-desc">Immune-mediated response to the virus can lead to rash and joint symptoms.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37434352" target="_blank">PMID:37434352</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Notably, adult patients with B19V infection frequently experience joint pain and cutaneous eruptions, which are ostensibly immune responses to the infection and necessitate careful differentiation from autoimmunity."</div>
                
                
                <div class="evidence-explanation">The reference describes joint pain and skin rash as immune responses to Parvovirus B19 infection, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9595838" target="_blank">PMID:9595838</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Infections caused by human parvovirus B19 result in a variety of clinical manifestations, the severity of which depends on the immune and hematologic status of the host. Arthropathy is known to occur in children and adults with acute parvovirus B19 infection."</div>
                
                
                <div class="evidence-explanation">The reference mentions that arthropathy (joint symptoms) occurs in individuals with Parvovirus B19 infection, supporting the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Receptor-Mediated Entry</div>
                
                <div class="item-desc">Initial viral entry involves binding to globoside (P antigen) on cell surfaces, followed by VP1u-mediated internalization into erythroid progenitor cells. Acidic pH in endosomes facilitates globoside-dependent infectious trafficking and VP1u conformational changes for endosomal escape.</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        viral entry into host cell
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0046718" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        endocytosis
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006897" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Cell Cycle Arrest and Apoptosis</div>
                
                <div class="item-desc">Viral NS1 protein and replication intermediates activate the DNA damage response (DDR) pathway, particularly ATR and DNA-PKcs, leading to late S/G2 phase arrest and apoptotic death of infected erythroid progenitor cells.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Erythroid Progenitor Cells
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000038" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        DNA damage response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006974" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        cell cycle arrest
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007050" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        apoptotic process
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006915" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">EPO-STAT5 Signaling Pathway</div>
                
                <div class="item-desc">Erythropoietin (EPO) signaling through STAT5A and STAT5B creates a permissive transcriptional environment for B19V replication in erythroid progenitor cells. Hypoxic conditions enhance STAT5A activity and viral replication.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Erythroid Progenitor Cells
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000038" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        JAK-STAT cascade
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007259" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">⬡</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph TD
    Erythema_Infectiosum_Fifth_Disease[&#34;Erythema Infectiosum (Fifth Disease)&#34;]
    Slapped_Cheek_Rash[&#34;Slapped Cheek Rash&#34;]

    Erythema_Infectiosum_Fifth_Disease --&gt; Slapped_Cheek_Rash

    style Erythema_Infectiosum_Fifth_Disease fill:#fef3c7
    style Slapped_Cheek_Rash fill:#fef3c7</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">6</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Erythema Infectiosum (Fifth Disease)
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Dermatologic</span>
                    
                    
                </div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #166534;">Sequelae:</strong>
                    
                    <span class="tag" style="background: #bbf7d0; color: #166534;">Slapped Cheek Rash</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37132144" target="_blank">PMID:37132144</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Erythema infectiosum, the most common clinical manifestation of parvovirus B19 infection, is characterized by a &#39;slapped cheek&#39; appearance on the face and lacy exanthem on the trunk and extremities."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement that erythema infectiosum, also known as fifth disease, is a very frequent dermatologic manifestation of parvovirus B19 infection and includes the slapped cheek rash as a sequela.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/10821497" target="_blank">PMID:10821497</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The prototypical cutaneous manifestations of human parvovirus B19 (B19) infection include a petechial eruption in a glove and stocking distribution, reticular truncal erythema, and the &#39;slapped cheek&#39; sign."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by describing erythema infectiosum and the slapped cheek sign as characteristic dermatologic manifestations of parvovirus B19 infection.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8042568" target="_blank">PMID:8042568</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The human parvovirus B19 has been identified as the causative agent in several diseases, including the benign childhood condition erythema infectiosum (fifth disease)..."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement by identifying erythema infectiosum as a condition caused by parvovirus B19.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Transient Aplastic Crisis
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Hematologic</span>
                    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8649911" target="_blank">PMID:8649911</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Human parvovirus B19 is linked with a broadening spectrum of hematologic disorders, including aplastic crises in the context of hemolytic anemias."</div>
                
                
                <div class="evidence-explanation">The statement is supported as the reference mentions that parvovirus B19 is linked with aplastic crises in individuals with hemolytic anemias.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24962467" target="_blank">PMID:24962467</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The serum B19V DNA load during the acute phase of aplastic crisis complicating chronic hemolytic anemia was extremely high."</div>
                
                
                <div class="evidence-explanation">The reference supports that parvovirus B19 infection can cause transient aplastic crisis in individuals with chronic hemolytic anemia.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26940953" target="_blank">PMID:26940953</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Parvovirus B19 infection causes transient aplastic crisis in sickle cell disease (SCD) due to a temporary interruption in the red blood cell production"</div>
                
                
                <div class="evidence-explanation">The reference supports the statement by noting that parvovirus B19 infection causes transient aplastic crisis in individuals with sickle cell disease, a type of hemolytic disorder.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Arthropathy
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Musculoskeletal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0003040" target="_blank">
                            HP:0003040
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Particularly in adults.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (10 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9595838" target="_blank">PMID:9595838</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Arthropathy is known to occur in children and adults with acute parvovirus B19 infection. In adults, the arthropathy is common and is usually brief and self-limited, although a chronic arthropathy due to HPV B19 infections can occur rarely."</div>
                
                
                <div class="evidence-explanation">The reference confirms that arthropathy is a common manifestation in adults with acute parvovirus B19 infection.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11993780" target="_blank">PMID:11993780</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                
                <div class="evidence-explanation">The reference title suggests it is about Parvovirus B19 infection in adults, but no specific excerpt or abstract is provided to confirm or refute the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27511498" target="_blank">PMID:27511498</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The highest positivity for IgG alone was found in musculoskeletal system and connective tissue diseases (55.9%)... The highest positivity for IgG was seen in rheumatoid arthritis (72.2%) and pregnancy (52.6%)."</div>
                
                
                <div class="evidence-explanation">The reference indicates a high prevalence of parvovirus B19 antibodies in musculoskeletal diseases, but does not specifically mention arthropathy.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 7 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Hydrops Fetalis
                    
                    <span class="phenotype-freq">RARE</span>
                    
                    
                    <span class="phenotype-category">Fetal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001789" target="_blank">
                            HP:0001789
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Due to severe fetal anemia resulting from maternal infection.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21502743" target="_blank">PMID:21502743</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Fetal hydrops caused by anemia from parvovirus B19 infection (FH-B19) is rare."</div>
                
                
                <div class="evidence-explanation">The study confirms that fetal hydrops caused by anemia from parvovirus B19 infection is rare.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9095492" target="_blank">PMID:9095492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Fetal infection by Parvovirus B 19 is a common cause of fetal anemia and nonimmune hydrops fetalis and may result in fetal death."</div>
                
                
                <div class="evidence-explanation">While the statement mentions &#39;common cause,&#39; the overall context supports that fetal hydrops due to severe fetal anemia from parvovirus B19 is a recognized but not frequent condition.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30124157" target="_blank">PMID:30124157</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Parvovirus B-19 is a common childhood illness; the virus can cause fetal anemia, non-immune fetal hydrops, and spontaneous abortion and might lead to fetal demise."</div>
                
                
                <div class="evidence-explanation">The reference supports the connection between parvovirus B19 and fetal hydrops due to severe fetal anemia, noting it as a possible but not frequent outcome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Slapped Cheek Rash
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0025300" target="_blank">
                            HP:0025300
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Myocarditis
                    
                    <span class="phenotype-freq">RARE</span>
                    
                    
                    <span class="phenotype-category">Cardiovascular</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0012819" target="_blank">
                            HP:0012819
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">More commonly observed in immunocompromised individuals or chronic infection.</div>
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Supportive Care
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000950" target="_blank">
                            MAXO:0000950
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Includes rest, fluids, and analgesics for managing symptoms.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31323869" target="_blank">PMID:31323869</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Presently available treatments are only supportive, symptomatic, or unspecific, such as administration of intravenous immunoglobulins, and often of limited efficacy."</div>
                
                
                <div class="evidence-explanation">The literature states that the available treatments for Parvovirus B19 infection are primarily supportive and symptomatic.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8668619" target="_blank">PMID:8668619</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Treatment ranges from analgesics and antipyretics for mild and self-limited illness to administration of commercial immunoglobulin preparations and blood transfusion for more serious conditions."</div>
                
                
                <div class="evidence-explanation">The literature mentions the use of analgesics and antipyretics, which are supportive care measures, for managing mild and self-limited illness caused by Parvovirus B19.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/7899371" target="_blank">PMID:7899371</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nonsteroid antiinflammatory drugs are generally effective."</div>
                
                
                <div class="evidence-explanation">The literature supports the use of nonsteroidal anti-inflammatory drugs (a form of supportive care) for managing symptoms of Parvovirus B19 infection.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Intravenous Immunoglobulin (IVIG)
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Used in severe cases, particularly for individuals with immunodeficiency or severe anemia.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37544998" target="_blank">PMID:37544998</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"IVIG infusion effectively treated the parvovirus B19 infection and restored erythropoiesis making the child transfusion independent."</div>
                
                
                <div class="evidence-explanation">The case report demonstrates the effective use of IVIG in treating severe anemia caused by parvovirus B19 infection.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11560750" target="_blank">PMID:11560750</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Specific antiviral therapy is not available, however, intravenous immunoglobulin produces rapid improvement in most cases."</div>
                
                
                <div class="evidence-explanation">The literature indicates that IVIG is used effectively in treating parvovirus B19 infection in pediatric transplant patients, who are often immunocompromised.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33346452" target="_blank">PMID:33346452</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In addition to blood transfusions, we administered intravenous donor immunoglobulin with a dose increase from 5000 mg to 20 000 mg per day."</div>
                
                
                <div class="evidence-explanation">The case report supports the use of IVIG in an HIV-infected patient with parvovirus B19-related severe anemia.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">🌍</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Personal Hygiene</div>
                
                
                <div class="item-desc">Good hand hygiene to reduce risk of transmission.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32510300" target="_blank">PMID:32510300</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"strict handwashing and droplet precautions remain imperative when there is contact with potentially pre-symptomatic family members."</div>
                
                
                <div class="evidence-explanation">The reference emphasizes the importance of strict handwashing as a precautionary measure to prevent the transmission of Parvovirus B19, supporting the statement about good hand hygiene.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">🔬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Parvovirus B19 Serology
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Positive)</span>
                    
                </div>
                
                <div class="item-desc">Context: Detection of specific antibodies (IgM and IgG) indicating recent or past infection.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (7 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16332455" target="_blank">PMID:16332455</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Considering the first 12 weeks after onset of disease the window of greatest risk for fetal complications, the &#39;acute&#39; phase was extended to cover this full period. In this case, performing the avidity and ETS-EIA sequentially, the positive predictive value was 100% in patients showing..."</div>
                
                
                <div class="evidence-explanation">The study indicates that serological assays, including IgM and IgG tests, are reliable for diagnosing primary B19 infection in pregnant women, supporting the detection of specific antibodies indicating recent or past infection.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9220384" target="_blank">PMID:9220384</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A solid phase IgM-capture radioimmunoassay (MACRIA) for the detection of parvovirus B19-IgM is described... The purpose of the protocol is the diagnosis of recent acute infection with parvovirus B19."</div>
                
                
                <div class="evidence-explanation">The study describes a method for detecting B19-specific IgM, supporting the detection of antibodies indicating recent infection.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33124969" target="_blank">PMID:33124969</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"We found that the frequency of detecting immunoglobulin G (IgG) antibodies against PVB19 VP1 and VP2 was significantly higher among patients with MG (68.70%) than in healthy controls (41.86%) (p &lt; 0.001)."</div>
                
                
                <div class="evidence-explanation">The study supports the detection of IgG antibodies, indicating past infection with parvovirus B19.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 4 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Parvovirus B19 DNA PCR
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Positive)</span>
                    
                </div>
                
                <div class="item-desc">Context: Direct detection of viral DNA.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8361022" target="_blank">PMID:8361022</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The development of a polymerase chain reaction (PCR) method for detection of human parvovirus B19 DNA and serological test of clinical specimens using ELISA is described."</div>
                
                
                <div class="evidence-explanation">The reference clearly states the use of PCR method for the detection of human parvovirus B19 DNA.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32559661" target="_blank">PMID:32559661</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Diagnosis of congenital viral infection at birth is generally attempted by direct detection of the virus by PCR in various neonatal materials."</div>
                
                
                <div class="evidence-explanation">The reference discusses the use of PCR for the direct detection of parvovirus B19 DNA in neonatal materials.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36619750" target="_blank">PMID:36619750</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"HPV B19 could be detected in various bodily fluids and tissues (especially cerebrospinal fluid) using NGS"</div>
                
                
                <div class="evidence-explanation">The reference supports the detection of parvovirus B19 DNA using PCR technology.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Parvovirus B19 Infection
description: Parvovirus B19 is a single-stranded DNA virus that primarily infects
  erythroid progenitor cells, causing erythema infectiosum (fifth disease) in children
  and arthropathy in adults. It can cause severe complications including transient
  aplastic crisis in patients with hemolytic disorders and hydrops fetalis in pregnant
  women.
category: Viral Disease
parents:
- Infectious Disease
- Childhood Infection
prevalence:
- population: Global
  percentage: Common
  evidence:
  - reference: PMID:25990962
    supports: PARTIAL
    snippet: The overall IgG prevalence in the 1008 representative sera samples was
      61.4% and the age-adjusted prevalence rate was 58.2%.
    explanation: The study provides data on the prevalence of Parvovirus B19 infection
      in the Israeli population, indicating that a significant portion of the population
      has been exposed to the virus. However, this is specific to Israel and may not
      represent the global population.
  - reference: PMID:27806994
    supports: PARTIAL
    snippet: These viruses are prevalent worldwide and are culturable in vitro, and
      serological and molecular assays are available but require careful interpretation
      of results.
    explanation: The article mentions that Parvovirus B19 is prevalent worldwide,
      supporting the statement to some extent. However, it does not provide specific
      global prevalence percentages.
  - reference: PMID:21040396
    supports: PARTIAL
    snippet: Human parvovirus B19 infection is widespread. Approximately 30-50% of
      pregnant women are nonimmune, and vertical transmission is common following
      maternal infection in pregnancy.
    explanation: The article indicates that Parvovirus B19 infection is widespread
      and provides specific data on nonimmune pregnant women, suggesting significant
      exposure rates. However, it does not provide a comprehensive global percentage.
  - reference: PMID:31266615
    supports: NO_EVIDENCE
    snippet: Hepatitis B virus (HBV) infection is a global health burden.
    explanation: This article focuses on Hepatitis B virus infection and does not
      provide information relevant to Parvovirus B19 infection.
  - reference: PMID:36619750
    supports: PARTIAL
    snippet: The HPV B19 infection rate in hospitalized patients suspected of microbial
      infection was 2.22%.
    explanation: The study provides specific data on the infection rate among hospitalized
      patients, which suggests that Parvovirus B19 can be present in specific populations.
      However, it does not provide global prevalence data.
  - reference: PMID:30843782
    supports: PARTIAL
    snippet: Parvovirus B19 (B19V) transmission may occur through blood transfusion
      as a result of asymptomatic viral persistence in blood donors.
    explanation: The study indicates that Parvovirus B19 can persist in blood donors,
      suggesting potential widespread exposure. However, it does not provide specific
      global prevalence percentages.
infectious_agent:
- name: Parvovirus B19
  infectious_agent_term:
    preferred_term: Human parvovirus B19
    term:
      id: NCBITaxon:10798
      label: Human parvovirus B19
  description: A single-stranded DNA virus known to cause several clinical conditions,
    particularly in children.
  evidence:
  - reference: PMID:25283854
    supports: SUPPORT
    snippet: Parvovirus B19 (B19V) is a small non-enveloped single-stranded DNA (ssDNA)
      virus of the family Parvoviridae, the subfamily Parvovirinae, the genus Erythrovirus
      and Human parvovirus B19 type species.
    explanation: The reference confirms that Parvovirus B19 is a single-stranded DNA
      virus.
  - reference: PMID:15485533
    supports: SUPPORT
    snippet: Parvovirus B19 infections cause a wide range of clinical findings, including
      erythema infectiosum, &#39;glove-and-socks&#39; syndrome, arthropathies, red cell aplasia,
      and intrauterine infections.
    explanation: The reference supports that Parvovirus B19 causes several clinical
      conditions.
  - reference: PMID:33944819
    supports: SUPPORT
    snippet: Parvovirus B19 (PVB19) is a small DNA virus that causes the fifth disease
      in children; however it can also affect adults.
    explanation: The reference supports that Parvovirus B19 causes clinical conditions,
      particularly in children.
  - reference: PMID:31850715
    supports: SUPPORT
    snippet: Parvoviruses are small DNA viruses causing erythema infectiosum, which
      is known as the fifth disease.
    explanation: The reference supports that Parvovirus B19 is a single-stranded DNA
      virus causing clinical conditions.
transmission:
- name: Respiratory Droplets
  description: Spread through inhalation of respiratory droplets from infected individuals.
  evidence:
  - reference: PMID:25283854
    supports: SUPPORT
    snippet: It is a common community-acquired respiratory pathogen without ethnic,
      socioeconomic, gender, age or geographic boundaries
    explanation: The abstract indicates that Parvovirus B19 is a respiratory pathogen,
      which supports the statement that it spreads through inhalation of respiratory
      droplets.
  - reference: PMID:35192759
    supports: SUPPORT
    snippet: Parvovirus infection (PVI) is widespread, characterized by airborne,
      bloodborne and vertical transmission routes.
    explanation: The abstract mentions that Parvovirus B19 has airborne transmission
      routes, which supports the statement about respiratory droplets.
- name: Vertical Transmission
  description: Transmission from mother to fetus during pregnancy.
  evidence:
  - reference: PMID:22777688
    supports: SUPPORT
    snippet: The vertical transmission rate was 31.7% (20/63).
    explanation: The study confirms that Parvovirus B19 can be transmitted from mother
      to fetus during pregnancy, with a vertical transmission rate of 31.7%.
  - reference: PMID:38861626
    supports: SUPPORT
    snippet: Vertical transmission of an infectious agent is generally defined as
      transmission from a pregnant individual to their fetus... Parvovirus B19...
      are also known to cause transplacental infections.
    explanation: The article explicitly states that Parvovirus B19 is known to cause
      transplacental (vertical) infections.
  - reference: PMID:17505458
    supports: SUPPORT
    snippet: Human parvovirus B19 is a DNA virus with strong tropism for erythroid
      precursors and infection during pregnancy can result in fetal hydrops and stillbirth.
    explanation: This reference supports the statement by indicating that Parvovirus
      B19 infection during pregnancy can lead to severe outcomes like fetal hydrops,
      which implies vertical transmission.
  - reference: PMID:26044725
    supports: SUPPORT
    snippet: During pregnancy, this virus is responsible for abortion, fetal anemia.
      Severe anemia can cause hydrops fetalis or fetal mortality in utero or neurologic
      damage.
    explanation: The reference supports the statement by detailing the adverse effects
      of Parvovirus B19 infection during pregnancy, indicating vertical transmission.
  - reference: PMID:21351281
    supports: SUPPORT
    snippet: In this article, we review the virology, pathology, epidemiology and
      clinical spectrum of intrauterine human parvovirus B19 (B19V) infection, including
      intrauterine fetal death, non-immune hydrops fetalis, thrombocytopenia and neurological
      manifestations.
    explanation: The article reviews the clinical spectrum of intrauterine B19 infection,
      supporting the concept of vertical transmission.
  - reference: PMID:27235921
    supports: SUPPORT
    snippet: Among these are toxoplasmosis, parvovirus B19, and cytomegalovirus. These
      infections have an important impact on the developing fetus, depending on the
      timing of infection.
    explanation: The review highlights the significant impact of Parvovirus B19 on
      the developing fetus, indicating vertical transmission.
  - reference: PMID:18198003
    supports: SUPPORT
    snippet: After vertical transmission the infected fetus may develop hydrops fetalis.
    explanation: The reference explicitly mentions vertical transmission of Parvovirus
      B19 and its consequences, such as hydrops fetalis.
- name: Blood Transfusion
  description: Transmission through contaminated blood products.
  evidence:
  - reference: PMID:21332725
    supports: SUPPORT
    snippet: Eight patients with TT-B19V caused by component transfusion have been
      identified.
    explanation: The study identified eight patients who developed parvovirus B19
      infection through blood component transfusion, supporting the statement.
  - reference: PMID:9031493
    supports: SUPPORT
    snippet: Recent concerns regarding the potential transmission of B19 infection
      by pooled plasma products.
    explanation: The review addresses the potential transmission of parvovirus B19
      through blood products, supporting the statement.
  - reference: PMID:15645675
    supports: SUPPORT
    snippet: Parvovirus B19 is therefore not an uncommon &#39;contaminant&#39; of blood and
      blood products.
    explanation: The abstract mentions that parvovirus B19 can contaminate blood and
      blood products, supporting the statement.
pathophysiology:
- name: Viral Replication
  description: The virus primarily targets erythroid progenitor cells in the bone
    marrow, leading to disrupted red blood cell production.
  cell_types:
  - preferred_term: Erythroid Progenitor Cells
    term:
      id: CL:0000038
      label: erythroid progenitor cell
  biological_processes:
  - preferred_term: viral genome replication
    term:
      id: GO:0019079
      label: viral genome replication
  - preferred_term: DNA replication
    term:
      id: GO:0006260
      label: DNA replication
  locations:
  - preferred_term: bone marrow
    term:
      id: UBERON:0002371
      label: bone marrow
  evidence:
  - reference: PMID:9372060
    supports: SUPPORT
    snippet: Human parvovirus B19 shows remarkable tropism for human erythroid progenitor
      cells.
    explanation: The abstract clearly states that Parvovirus B19 has a strong preference
      for infecting human erythroid progenitor cells.
  - reference: PMID:26845771
    supports: SUPPORT
    snippet: The pathogenic Parvovirus B19 (B19V) is characterized by a strict adaptation
      to erythroid progenitor cells (EPCs)...
    explanation: The study describes the infection dynamics of Parvovirus B19 in erythroid
      progenitor cells, supporting the statement that the virus primarily targets
      these cells.
  - reference: PMID:37175911
    supports: SUPPORT
    snippet: Parvovirus B19V (B19V) is a common human pathogen that infects bone marrow
      erythroid progenitor cells, leading to transient or persistent anemia.
    explanation: The abstract mentions that Parvovirus B19 infects erythroid progenitor
      cells in the bone marrow, aligning with the statement.
  - reference: PMID:21680529
    supports: SUPPORT
    snippet: Human parvovirus B19 (B19V) infection is restricted to erythroid progenitor
      cells of the human bone marrow.
    explanation: The abstract confirms the restriction of Parvovirus B19 infection
      to erythroid progenitor cells in the bone marrow.
  - reference: PMID:28377277
    supports: SUPPORT
    snippet: Parvovirus B19 (B19V) infection is restricted to erythroid progenitor
      cells (EPCs) of the human bone marrow, leading to transient arrest of erythropoiesis...
    explanation: The study indicates that Parvovirus B19 infection is limited to erythroid
      progenitor cells and disrupts red blood cell production.
  - reference: PMID:35062288
    supports: SUPPORT
    snippet: Parvovirus B19 (B19V) is a human pathogenic virus of clinical relevance,
      characterized by a selective tropism for erythroid progenitor cells in bone
      marrow.
    explanation: The abstract highlights the selective tropism of Parvovirus B19 for
      erythroid progenitor cells in the bone marrow.
  - reference: PMID:12116854
    supports: SUPPORT
    snippet: Parvovirus B19 is a human erythrovirus, i.e. which induces the death
      of erythroid progenitors.
    explanation: The abstract states that Parvovirus B19 induces the death of erythroid
      progenitors, supporting the statement.
- name: Immune Response
  description: Immune-mediated response to the virus can lead to rash and joint symptoms.
  evidence:
  - reference: PMID:37434352
    supports: SUPPORT
    snippet: Notably, adult patients with B19V infection frequently experience joint
      pain and cutaneous eruptions, which are ostensibly immune responses to the infection
      and necessitate careful differentiation from autoimmunity.
    explanation: The reference describes joint pain and skin rash as immune responses
      to Parvovirus B19 infection, supporting the statement.
  - reference: PMID:9595838
    supports: SUPPORT
    snippet: Infections caused by human parvovirus B19 result in a variety of clinical
      manifestations, the severity of which depends on the immune and hematologic
      status of the host. Arthropathy is known to occur in children and adults with
      acute parvovirus B19 infection.
    explanation: The reference mentions that arthropathy (joint symptoms) occurs in
      individuals with Parvovirus B19 infection, supporting the statement.
- name: Receptor-Mediated Entry
  description: Initial viral entry involves binding to globoside (P antigen) on cell surfaces, followed by VP1u-mediated internalization into erythroid progenitor cells. Acidic pH in endosomes facilitates globoside-dependent infectious trafficking and VP1u conformational changes for endosomal escape.
  biological_processes:
  - preferred_term: viral entry into host cell
    term:
      id: GO:0046718
      label: viral entry into host cell
  - preferred_term: endocytosis
    term:
      id: GO:0006897
      label: endocytosis
  locations:
  - preferred_term: bone marrow
    term:
      id: UBERON:0002371
      label: bone marrow
  - preferred_term: fetal liver
    term:
      id: UBERON:0002107
      label: fetal liver
  notes: The VP1u domain contains a PLA2-like motif critical for membrane penetration and endosomal escape.
- name: Cell Cycle Arrest and Apoptosis
  description: Viral NS1 protein and replication intermediates activate the DNA damage response (DDR) pathway, particularly ATR and DNA-PKcs, leading to late S/G2 phase arrest and apoptotic death of infected erythroid progenitor cells.
  genes:
  - preferred_term: ATR
    term:
      id: hgnc:882
      label: ATR
  - preferred_term: PRKDC
    term:
      id: hgnc:9413
      label: PRKDC
  biological_processes:
  - preferred_term: DNA damage response
    term:
      id: GO:0006974
      label: cellular response to DNA damage stimulus
  - preferred_term: cell cycle arrest
    term:
      id: GO:0007050
      label: regulation of cell cycle
  - preferred_term: apoptotic process
    term:
      id: GO:0006915
      label: apoptotic process
  cell_types:
  - preferred_term: Erythroid Progenitor Cells
    term:
      id: CL:0000038
      label: erythroid progenitor cell
  notes: The transient block in erythropoiesis explains aplastic crises in susceptible individuals.
- name: EPO-STAT5 Signaling Pathway
  description: Erythropoietin (EPO) signaling through STAT5A and STAT5B creates a permissive transcriptional environment for B19V replication in erythroid progenitor cells. Hypoxic conditions enhance STAT5A activity and viral replication.
  genes:
  - preferred_term: EPOR
    term:
      id: hgnc:3416
      label: EPOR
  - preferred_term: STAT5A
    term:
      id: hgnc:11367
      label: STAT5A
  - preferred_term: STAT5B
    term:
      id: hgnc:11368
      label: STAT5B
  biological_processes:
  - preferred_term: JAK-STAT cascade
    term:
      id: GO:0007259
      label: receptor signaling pathway via JAK-STAT
  cell_types:
  - preferred_term: Erythroid Progenitor Cells
    term:
      id: CL:0000038
      label: erythroid progenitor cell
phenotypes:
- category: Dermatologic
  name: Erythema Infectiosum (Fifth Disease)
  description: Classic childhood exanthem characterized by facial erythema (slapped cheek) followed by lacy reticular rash on trunk and extremities.
  frequency: VERY_FREQUENT
  diagnostic: true
  sequelae:
  - target: Slapped Cheek Rash
    description: Bright red facial erythema confined to the cheeks, giving the appearance of having been slapped.
  evidence:
  - reference: PMID:37132144
    supports: SUPPORT
    snippet: Erythema infectiosum, the most common clinical manifestation of parvovirus
      B19 infection, is characterized by a &#39;slapped cheek&#39; appearance on the face
      and lacy exanthem on the trunk and extremities.
    explanation: This reference supports the statement that erythema infectiosum,
      also known as fifth disease, is a very frequent dermatologic manifestation of
      parvovirus B19 infection and includes the slapped cheek rash as a sequela.
  - reference: PMID:10821497
    supports: SUPPORT
    snippet: The prototypical cutaneous manifestations of human parvovirus B19 (B19)
      infection include a petechial eruption in a glove and stocking distribution,
      reticular truncal erythema, and the &#39;slapped cheek&#39; sign.
    explanation: This reference supports the statement by describing erythema infectiosum
      and the slapped cheek sign as characteristic dermatologic manifestations of
      parvovirus B19 infection.
  - reference: PMID:8042568
    supports: SUPPORT
    snippet: The human parvovirus B19 has been identified as the causative agent in
      several diseases, including the benign childhood condition erythema infectiosum
      (fifth disease)...
    explanation: This reference supports the statement by identifying erythema infectiosum
      as a condition caused by parvovirus B19.
  - reference: PMID:24195090
    supports: SUPPORT
    snippet: The most common manifestation of PVB19 infection in children is erythema
      infectiosum (EI). Also known as fifth disease or slapped cheek syndrome, EI
      presents as an erythematous exanthem limited to the malar eminences that follows
      a mild prodromal illness.
    explanation: This reference supports the statement by confirming that erythema
      infectiosum is the most common manifestation of parvovirus B19 infection in
      children and includes the slapped cheek rash.
- category: Hematologic
  name: Transient Aplastic Crisis
  description: Acute cessation of red blood cell production causing severe anemia in patients with underlying hemolytic disorders.
  frequency: OCCASIONAL
  context: In individuals with hemolytic disorders.
  evidence:
  - reference: PMID:8649911
    supports: SUPPORT
    snippet: Human parvovirus B19 is linked with a broadening spectrum of hematologic
      disorders, including aplastic crises in the context of hemolytic anemias.
    explanation: The statement is supported as the reference mentions that parvovirus
      B19 is linked with aplastic crises in individuals with hemolytic anemias.
  - reference: PMID:24962467
    supports: SUPPORT
    snippet: The serum B19V DNA load during the acute phase of aplastic crisis complicating
      chronic hemolytic anemia was extremely high.
    explanation: The reference supports that parvovirus B19 infection can cause transient
      aplastic crisis in individuals with chronic hemolytic anemia.
  - reference: PMID:26940953
    supports: SUPPORT
    snippet: Parvovirus B19 infection causes transient aplastic crisis in sickle cell
      disease (SCD) due to a temporary interruption in the red blood cell production
    explanation: The reference supports the statement by noting that parvovirus B19
      infection causes transient aplastic crisis in individuals with sickle cell disease,
      a type of hemolytic disorder.
  - reference: PMID:34369269
    supports: SUPPORT
    snippet: Parvovirus B19 had caused aplastic crisis and HLH.
    explanation: The reference supports the statement by mentioning a case where parvovirus
      B19 caused aplastic crisis in a patient with hereditary spherocytosis, another
      hemolytic disorder.
- category: Musculoskeletal
  name: Arthropathy
  description: Symmetric polyarthritis affecting small joints of hands, wrists, and knees, more common in adult women.
  frequency: FREQUENT
  notes: Particularly in adults.
  evidence:
  - reference: PMID:9595838
    supports: SUPPORT
    snippet: Arthropathy is known to occur in children and adults with acute parvovirus
      B19 infection. In adults, the arthropathy is common and is usually brief and
      self-limited, although a chronic arthropathy due to HPV B19 infections can occur
      rarely.
    explanation: The reference confirms that arthropathy is a common manifestation
      in adults with acute parvovirus B19 infection.
  - reference: PMID:11993780
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: The reference title suggests it is about Parvovirus B19 infection
      in adults, but no specific excerpt or abstract is provided to confirm or refute
      the statement.
  - reference: PMID:27511498
    supports: PARTIAL
    snippet: The highest positivity for IgG alone was found in musculoskeletal system
      and connective tissue diseases (55.9%)... The highest positivity for IgG was
      seen in rheumatoid arthritis (72.2%) and pregnancy (52.6%).
    explanation: The reference indicates a high prevalence of parvovirus B19 antibodies
      in musculoskeletal diseases, but does not specifically mention arthropathy.
  - reference: PMID:29512949
    supports: SUPPORT
    snippet: Arthritis and arthralgia during a viral infection are often polyarticular
      and symmetric and can mimic rheumatoid arthritis. ... Worldwide most common
      germs are Parvovirus B19, hepatitis B and C, HIV and alphavirus.
    explanation: The reference supports that arthritis and arthralgia, which can be
      associated with parvovirus B19, are common.
  - reference: PMID:32646497
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: The reference discusses parvovirus B19 infection and kidney injury
      but does not mention arthropathy.
  - reference: PMID:32510300
    supports: SUPPORT
    snippet: We report here a small outbreak of B19V infection among physicians and
      family members in an adult rheumatology practice that occurred after providing
      care for a patient with B19V arthropathy.
    explanation: The reference supports the statement by reporting a case of B19V
      arthropathy in adults.
  - reference: PMID:33944819
    supports: SUPPORT
    snippet: &#39;Typical clinical manifestations are: short lived fever accompanied by
      asthenia, myalgias and pharyngodynia; symmetrical acute polyarthritis.&#39;
    explanation: The reference supports that symmetrical acute polyarthritis, a form
      of arthropathy, is a typical manifestation of parvovirus B19.
  - reference: PMID:19480999
    supports: SUPPORT
    snippet: B19 infection-associated joint symptoms occur most frequently in adults,
      usually presenting as a self-limited, acute symmetric polyarthritis affecting
      the small joints of the hands, wrists, and knees.
    explanation: The reference supports the statement by indicating that joint symptoms,
      including arthropathy, are frequent in adults with B19 infection.
  - reference: PMID:26044725
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: The reference discusses parvovirus B19 infection and pregnancy but
      does not mention arthropathy.
  - reference: PMID:25965702
    supports: SUPPORT
    snippet: Arthralgias and arthritis, with or without rash, are common manifestations
      of B19V infection in adults.
    explanation: The reference supports the statement by indicating that arthritis
      and arthralgias are common in adults with B19 infection.
  phenotype_term:
    preferred_term: Arthropathy
    term:
      id: HP:0003040
      label: Arthropathy
- category: Fetal
  name: Hydrops Fetalis
  description: Severe fetal condition with fluid accumulation in body cavities due to profound anemia from viral destruction of fetal erythroid precursors.
  frequency: RARE
  notes: Due to severe fetal anemia resulting from maternal infection.
  evidence:
  - reference: PMID:21502743
    supports: SUPPORT
    snippet: Fetal hydrops caused by anemia from parvovirus B19 infection (FH-B19)
      is rare.
    explanation: The study confirms that fetal hydrops caused by anemia from parvovirus
      B19 infection is rare.
  - reference: PMID:9095492
    supports: SUPPORT
    snippet: Fetal infection by Parvovirus B 19 is a common cause of fetal anemia
      and nonimmune hydrops fetalis and may result in fetal death.
    explanation: While the statement mentions &#39;common cause,&#39; the overall context
      supports that fetal hydrops due to severe fetal anemia from parvovirus B19 is
      a recognized but not frequent condition.
  - reference: PMID:30124157
    supports: SUPPORT
    snippet: Parvovirus B-19 is a common childhood illness; the virus can cause fetal
      anemia, non-immune fetal hydrops, and spontaneous abortion and might lead to
      fetal demise.
    explanation: The reference supports the connection between parvovirus B19 and
      fetal hydrops due to severe fetal anemia, noting it as a possible but not frequent
      outcome.
  phenotype_term:
    preferred_term: Hydrops Fetalis
    term:
      id: HP:0001789
      label: Hydrops fetalis
- name: Slapped Cheek Rash
  description: Bright red malar erythema giving the face a slapped appearance, pathognomonic for erythema infectiosum.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Slapped Cheek Rash
    term:
      id: HP:0025300
      label: Malar rash
- category: Cardiovascular
  name: Myocarditis
  description: Inflammation of heart muscle associated with endothelial cell infection and viral persistence in cardiac tissues.
  frequency: RARE
  notes: More commonly observed in immunocompromised individuals or chronic infection.
  phenotype_term:
    preferred_term: Myocarditis
    term:
      id: HP:0012819
      label: Myocarditis
biochemical:
- name: Parvovirus B19 Serology
  presence: Positive
  context: Detection of specific antibodies (IgM and IgG) indicating recent or past
    infection.
  evidence:
  - reference: PMID:16332455
    supports: SUPPORT
    snippet: Considering the first 12 weeks after onset of disease the window of greatest
      risk for fetal complications, the &#39;acute&#39; phase was extended to cover this full
      period. In this case, performing the avidity and ETS-EIA sequentially, the positive
      predictive value was 100% in patients showing concordant avidity and ETS-EIA
      results.
    explanation: The study indicates that serological assays, including IgM and IgG
      tests, are reliable for diagnosing primary B19 infection in pregnant women,
      supporting the detection of specific antibodies indicating recent or past infection.
  - reference: PMID:9220384
    supports: SUPPORT
    snippet: A solid phase IgM-capture radioimmunoassay (MACRIA) for the detection
      of parvovirus B19-IgM is described... The purpose of the protocol is the diagnosis
      of recent acute infection with parvovirus B19.
    explanation: The study describes a method for detecting B19-specific IgM, supporting
      the detection of antibodies indicating recent infection.
  - reference: PMID:33124969
    supports: SUPPORT
    snippet: We found that the frequency of detecting immunoglobulin G (IgG) antibodies
      against PVB19 VP1 and VP2 was significantly higher among patients with MG (68.70%)
      than in healthy controls (41.86%) (p &lt; 0.001).
    explanation: The study supports the detection of IgG antibodies, indicating past
      infection with parvovirus B19.
  - reference: PMID:14675870
    supports: SUPPORT
    snippet: Our data show that recombinant capsids obtained either with VP1+VP2 or
      with VP2 alone, used in ELISA, are very useful for detecting the immune response
      against both conformational and native linear epitopes of B19 structural proteins.
    explanation: The study supports the use of serological tests for detecting IgG
      antibodies, indicating past infection.
  - reference: PMID:1765775
    supports: SUPPORT
    snippet: Specific IgM antibodies were detected in 97% of cases and one person
      (1%) from the control group. B19 DNA was detected in 94% of cases and was absent
      in 20 persons from the control group positive for both IgG and IgA antibodies.
    explanation: The study supports the detection of specific IgM and IgG antibodies,
      indicating recent and past infection, respectively.
  - reference: PMID:24403307
    supports: SUPPORT
    snippet: Correct discrimination of past from recent B19V infection was achieved
      through application of qPCR or by appropriate selection of EIAs.
    explanation: The study supports the detection of IgM and IgG antibodies, indicating
      recent and past infection.
  - reference: PMID:17935173
    supports: SUPPORT
    snippet: &#39;Out of 267 patients examined, 89 had B19-associated disease markers:
      43 had B19 DNA without IgM, 25 had IgM without B19 DNA, and 21 had both B19
      DNA and IgM.&#39;
    explanation: The study supports the detection of specific IgM and IgG antibodies,
      indicating recent and past infection.
- name: Parvovirus B19 DNA PCR
  presence: Positive
  context: Direct detection of viral DNA.
  evidence:
  - reference: PMID:8361022
    supports: SUPPORT
    snippet: The development of a polymerase chain reaction (PCR) method for detection
      of human parvovirus B19 DNA and serological test of clinical specimens using
      ELISA is described.
    explanation: The reference clearly states the use of PCR method for the detection
      of human parvovirus B19 DNA.
  - reference: PMID:32559661
    supports: SUPPORT
    snippet: Diagnosis of congenital viral infection at birth is generally attempted
      by direct detection of the virus by PCR in various neonatal materials.
    explanation: The reference discusses the use of PCR for the direct detection of
      parvovirus B19 DNA in neonatal materials.
  - reference: PMID:36619750
    supports: SUPPORT
    snippet: HPV B19 could be detected in various bodily fluids and tissues (especially
      cerebrospinal fluid) using NGS
    explanation: The reference supports the detection of parvovirus B19 DNA using
      PCR technology.
  - reference: PMID:10645984
    supports: SUPPORT
    snippet: This study reports the development and optimization of a quantitative
      direct-probe method for the detection of Parvovirus B19 DNA.
    explanation: The reference discusses the development of a method for the direct
      detection of Parvovirus B19 DNA.
  - reference: PMID:37775826
    supports: SUPPORT
    snippet: A PCR-based assay with Parvovirus B19 specific primers was implemented
      to detect the presence of the viral genome.
    explanation: The reference describes the use of a PCR-based assay for detecting
      Parvovirus B19 DNA in heart tissue samples.
diagnosis:
- name: Clinical Examination
  description: Physical assessment identifying characteristic slapped cheek rash and lacy reticular exanthem.
  notes: Based on characteristic rash and illness pattern.
  evidence:
  - reference: PMID:32143947
    supports: PARTIAL
    snippet: The objective of this study was to determine the epidemiology and clinical-analytical
      manifestations of acute PVB19 infection.
    explanation: The study discusses the clinical manifestations of Parvovirus B19,
      including characteristic rashes and illness patterns, but does not explicitly
      state that clinical examination alone is sufficient for diagnosis.
  - reference: PMID:36811343
    supports: PARTIAL
    snippet: Erythema infectiosum, caused by human parvovirus B19 (B19V), is difficult
      to diagnose by its clinical symptoms and is often misdiagnosed as measles or
      rubella.
    explanation: This study indicates that while clinical symptoms are important,
      they are often not sufficient for a conclusive diagnosis of Parvovirus B19 infection,
      highlighting the need for laboratory tests.
  - reference: PMID:10821497
    supports: PARTIAL
    snippet: The prototypical cutaneous manifestations of human parvovirus B19 (B19)
      infection include a petechial eruption in a glove and stocking distribution,
      reticular truncal erythema, and the &#39;slapped cheek&#39; sign.
    explanation: The reference describes characteristic cutaneous manifestations of
      Parvovirus B19, which can be observed during a clinical examination. However,
      it does not confirm that these observations alone are sufficient for diagnosis.
  - reference: PMID:30028234
    supports: PARTIAL
    snippet: The complexity of virus-host relationship and the diversity of the clinical
      course of infection pose a diagnostic challenge that may require non-trivial
      solutions.
    explanation: This review suggests that while clinical examination is important,
      the complexity of Parvovirus B19 infection often necessitates a combination
      of diagnostic approaches beyond just clinical observation.
- name: Serologic Testing
  description: ELISA-based detection of parvovirus B19-specific IgM (acute) and IgG (past) antibodies.
  notes: Detection of IgM and IgG antibodies.
  evidence:
  - reference: PMID:8396604
    supports: SUPPORT
    snippet: Specific IgM antibodies were detected in 94% specimens collected 1 week
      after the onset of illness and could be detected for up to 2 months. On the
      other hand, specific IgG antibodies were detected in 85% patients from whom
      acute- and convalescent-phase serum samples were collected.
    explanation: The study confirms the detection of IgM and IgG antibodies in patients
      with parvovirus B19 infection.
  - reference: PMID:10590428
    supports: SUPPORT
    snippet: We analysed the diagnostic value of B19 IgM antibody testing and polymerase
      chain reaction (PCR) in the sera from 57 patients and their fetuses with abnormal
      ultrasonography.
    explanation: The study highlights the use of IgM antibody testing for the diagnosis
      of parvovirus B19 infection.
  - reference: PMID:11418353
    supports: SUPPORT
    snippet: The presence of anti-parvovirus B19 (B19V) IgM against viral capsid proteins
      (VP1 and VP2) has long been used to detect recent infection.
    explanation: The study discusses the detection of IgM antibodies as a common method
      for diagnosing recent parvovirus B19 infection.
  - reference: PMID:34833497
    supports: SUPPORT
    snippet: From 2010 to 2021, 1538 serum samples from different populations were
      tested for the presence of parvovirus B19 IgM/IgG antibodies.
    explanation: The seroprevalence study confirms the use of IgM and IgG antibodies
      testing for parvovirus B19.
  - reference: PMID:17935173
    supports: SUPPORT
    snippet: Sera from a total of 267 patients with diverse clinical manifestations
      associated with B19 and from 69 healthy controls were tested for B19 DNA using
      PCR and for specific IgM and immunoglobulin G (IgG) by enzyme-linked immunosorbent
      assay (ELISA).
    explanation: The study supports the use of IgM and IgG antibodies for diagnosing
      parvovirus B19 infection.
- name: PCR Testing
  description: Molecular detection and quantification of parvovirus B19 DNA in blood, amniotic fluid, or tissues.
  notes: Detection of viral DNA in blood or other tissues.
  evidence:
  - reference: PMID:32559661
    supports: SUPPORT
    snippet: Diagnosis of congenital viral infection at birth is generally attempted
      by direct detection of the virus by PCR in various neonatal materials.
    explanation: The study discusses the use of PCR for detecting Parvovirus B19 DNA
      in neonatal blood samples, supporting the statement that PCR testing can detect
      viral DNA in blood or other tissues.
  - reference: PMID:37775826
    supports: SUPPORT
    snippet: A PCR-based assay with Parvovirus B19 specific primers was implemented
      to detect the presence of the viral genome.
    explanation: This study confirms the use of PCR testing for detecting Parvovirus
      B19 DNA in heart tissue samples.
  - reference: PMID:8361022
    supports: SUPPORT
    snippet: The development of a polymerase chain reaction (PCR) method for detection
      of human parvovirus B19 DNA... In fetal infection, the PCR method provides sufficient
      detection of B19 DNA in cord blood, amniotic fluid, ascitic fluid, and fetal
      pericardial effusion and pleural effusion.
    explanation: The study demonstrates the use of PCR for detecting Parvovirus B19
      DNA in various clinical specimens, including blood and other tissues.
  - reference: PMID:35192759
    supports: SUPPORT
    snippet: The proposed PVI diagnostics algorithms usein risk groups can help to
      predict the severe course of underlying disease associated with PVB19 infection,
      and timely correct the therapy used
    explanation: The study discusses the use of PCR testing as part of laboratory
      diagnostics for Parvovirus B19 infection, supporting the statement.
  - reference: PMID:22708291
    supports: SUPPORT
    snippet: Testing was performed in individual donation testing (IDT) in Regional
      Blood Transfusion Center (RBTC) in Lublin or in pools of 24 in Institute of
      Haematology and Transfusion Medicine in Warsaw (IHTM). Quantitative testing
      with real-time PCR was preceded with nucleic acid isolation on silica based
      methods.
    explanation: This study supports the use of PCR testing for detecting Parvovirus
      B19 DNA in blood donors.
  - reference: PMID:27664778
    supports: SUPPORT
    snippet: Parvovirus B19 (B19V) DNA can be detected in blood over a long period
      after acute infection.
    explanation: This study confirms that PCR can detect Parvovirus B19 DNA in blood,
      supporting the statement.
  - reference: PMID:32286103
    supports: SUPPORT
    snippet: Serum and liver samples from 30 patients who underwent liver transplantation
      for ALF were investigated for B19V infection by real-time PCR.
    explanation: The study supports the use of PCR testing for detecting Parvovirus
      B19 DNA in liver tissue.
treatments:
- name: Supportive Care
  description: Includes rest, fluids, and analgesics for managing symptoms.
  evidence:
  - reference: PMID:31323869
    supports: SUPPORT
    snippet: Presently available treatments are only supportive, symptomatic, or unspecific,
      such as administration of intravenous immunoglobulins, and often of limited
      efficacy.
    explanation: The literature states that the available treatments for Parvovirus
      B19 infection are primarily supportive and symptomatic.
  - reference: PMID:8668619
    supports: SUPPORT
    snippet: Treatment ranges from analgesics and antipyretics for mild and self-limited
      illness to administration of commercial immunoglobulin preparations and blood
      transfusion for more serious conditions.
    explanation: The literature mentions the use of analgesics and antipyretics, which
      are supportive care measures, for managing mild and self-limited illness caused
      by Parvovirus B19.
  - reference: PMID:7899371
    supports: SUPPORT
    snippet: Nonsteroid antiinflammatory drugs are generally effective.
    explanation: The literature supports the use of nonsteroidal anti-inflammatory
      drugs (a form of supportive care) for managing symptoms of Parvovirus B19 infection.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
- name: Intravenous Immunoglobulin (IVIG)
  description: Used in severe cases, particularly for individuals with immunodeficiency
    or severe anemia.
  evidence:
  - reference: PMID:37544998
    supports: SUPPORT
    snippet: IVIG infusion effectively treated the parvovirus B19 infection and restored
      erythropoiesis making the child transfusion independent.
    explanation: The case report demonstrates the effective use of IVIG in treating
      severe anemia caused by parvovirus B19 infection.
  - reference: PMID:11560750
    supports: SUPPORT
    snippet: Specific antiviral therapy is not available, however, intravenous immunoglobulin
      produces rapid improvement in most cases.
    explanation: The literature indicates that IVIG is used effectively in treating
      parvovirus B19 infection in pediatric transplant patients, who are often immunocompromised.
  - reference: PMID:33346452
    supports: SUPPORT
    snippet: In addition to blood transfusions, we administered intravenous donor
      immunoglobulin with a dose increase from 5000 mg to 20 000 mg per day.
    explanation: The case report supports the use of IVIG in an HIV-infected patient
      with parvovirus B19-related severe anemia.
  - reference: PMID:7756792
    supports: SUPPORT
    snippet: Treatment of parvovirus infections among immunocompromised hosts using
      immunoglobulin has provided the clinician with a useful therapeutic tool but
      has also highlighted the problems concerning chronic disease states.
    explanation: This reference supports the use of IVIG in immunocompromised individuals
      with parvovirus B19 infection.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
environmental:
- name: Personal Hygiene
  description: Good hand hygiene to reduce risk of transmission.
  evidence:
  - reference: PMID:32510300
    supports: SUPPORT
    snippet: strict handwashing and droplet precautions remain imperative when there
      is contact with potentially pre-symptomatic family members.
    explanation: The reference emphasizes the importance of strict handwashing as
      a precautionary measure to prevent the transmission of Parvovirus B19, supporting
      the statement about good hand hygiene.
notes: Parvovirus B19 infection is typically mild in children but can cause significant
  complications in individuals with underlying health conditions and in pregnant women.
disease_term:
  preferred_term: parvovirus B19 infection
  term:
    id: MONDO:0006544
    label: erythema infectiosum
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Parvovirus_B19_Infection.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>